. Can we learn lessons from the FDA's approval of aducanumab?. Nat Rev Neurol. 2021 Nov;17(11):715-722. Epub 2021 Sep 17 PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.